KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Gross Margin (2016 - 2025)

Zimmer Biomet Holdings has reported Gross Margin over the past 17 years, most recently at 64.68% for Q4 2025.

  • Quarterly results put Gross Margin at 64.68% for Q4 2025, down 632.0% from a year ago — trailing twelve months through Dec 2025 was 69.71% (down 176.0% YoY), and the annual figure for FY2025 was 69.71%, down 176.0%.
  • Gross Margin for Q4 2025 was 64.68% at Zimmer Biomet Holdings, down from 72.05% in the prior quarter.
  • Over the last five years, Gross Margin for ZBH hit a ceiling of 72.88% in Q1 2024 and a floor of 64.68% in Q4 2025.
  • Median Gross Margin over the past 5 years was 71.41% (2025), compared with a mean of 71.06%.
  • Peak annual rise in Gross Margin hit 648bps in 2021, while the deepest fall reached -1373bps in 2021.
  • Zimmer Biomet Holdings' Gross Margin stood at 69.81% in 2021, then increased by 2bps to 71.49% in 2022, then increased by 1bps to 72.23% in 2023, then dropped by -2bps to 71.0% in 2024, then fell by -9bps to 64.68% in 2025.
  • The last three reported values for Gross Margin were 64.68% (Q4 2025), 72.05% (Q3 2025), and 71.49% (Q2 2025) per Business Quant data.